Clinical Trials Browser

Peripheral Nervous System Diseases, Colorectal Neoplasms

NCT07245095 2025-11-24

NACSIMET

Phase 2 Recruiting

132 enrolled

Gastrointestinal

Stomach Neoplasms

NCT06039280 2023-09-15

Comparison of Dexamethasone and N Acetylcysteine (NAC) Versus N Acetylcysteine (NAC) Alone in the Prevention of Post Embolization Syndrome in Patients With Hepatocellular Carcinoma Following Transarterial Chemoembolization.

Phase NA Unknown

150 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT02094625 2023-04-18

NAC to Prevent Cisplatin-induced Hearing Loss

Phase 1 Completed

52 enrolled

GastrointestinalSarcoma

Liver Neoplasms, Osteosarcoma, Neuroectodermal Tumors, Primitive, Hearing Loss

NCT01653171 2018-04-10

PRUE

Phase 4 Completed

230 enrolled

Gastrointestinal

Stomach Neoplasms

NCT01726465 2013-11-13

MENHIR

Phase 2 Terminated

50 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT01394497 2013-02-18

Use of N-Acetylcysteine During Liver Procurement

Phase 2 Completed

140 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Liver Failure, Liver Failure, Acute, Primary Graft Dysfunction

NCT00196885 2008-06-20

Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training

Phase 2 Completed

60 enrolled

GastrointestinalLymphoid

Carcinoma, Bronchogenic, Gastrointestinal Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Muscular Atrophy, Weight Loss

Clinical Trials

Protective Effect of N-acetylcysteine on Oxaliplatin-Induced Neuropathy in Colorectal Cancer

NACSIMET

Comparison of Dexamethasone and N Acetylcysteine (NAC) Versus N Acetylcysteine (NAC) Alone in the Prevention of Post Embolization Syndrome in Patients With Hepatocellular Carcinoma Following Transarterial Chemoembolization.

NAC to Prevent Cisplatin-induced Hearing Loss

PRUE

MENHIR

Use of N-Acetylcysteine During Liver Procurement

Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training